Michelle S. Cespedes, MD, MS

Icahn School of Medicine at Mount Sinai

Disclosure(s): Aspire Scientific: Medical writing support; Gilead Sciences, Inc.: Medical writing support; ViiV Healthcare: Advisor/Consultant

Poster(s):

• (P-305) No Clinically Significant Drug–Drug Interactions with Co-administration of Feminizing or Masculinizing Hormone Therapy and Twice-yearly Lenacapavir PrEP in Gender-Diverse Persons
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET